Serum Autoantibody Lowering by the Anti-FcRn Monoclonal Antibody, Nipocalimab, Correlates With Clinical Improvement in Generalized Myasthenia Gravis Patients.
- Resource Type
- Article
- Source
- Neurology; 12/5/2022 Suppl 2, Vol. 99, pS35-S37, 3p
- Subject
- Language
- ISSN
- 00283878